8 completed, 3 unknown, 2 terminated, 1 active not recruiting. 17 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 8, Unknown 3, Terminated 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hematologic Tests: new trials by email Literature Review of Hematologic Tests trials Research Report on Hematologic Tests
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests - NSCLC | Phase 2 | Recruiting | Groupe Francais De Pneumo-Cancerologie | 45 | 2025-06-19 | 2026-04-29 |
| Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies MGCND00EP1, Placebo, ECG - Resistant Epilepsy, Drug, Adolescent Epilepsy | Phase 2 | Withdrawn | MGC Pharmaceuticals d.o.o | 2024-05-30 | 2024-06-03 | |
| A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic | Phase 2 / Phase 3 | Completed | University of Leicester | 66 | 2023-12-05 | 2026-07-22 |
| Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients Blood test - Cancer of Colon, Interleukins | Phase 2 | Completed | Soonchunhyang University Hospital | 75 | 2023-09-04 | 2024-06-12 |
| Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias C-11 ER-176, Blood Test - Lewy Body Dementia (LBD), Alzheimer Dementia (AD) | Phase 2 | Enrolling by invitation | Val Lowe | 125 | 2021-03-30 | 2026-05-22 |
| Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. Active drug: pimavanserin 17mg (2 strength tablets), Placebo: 2 tablets containing same excipients except active compound, Assessment of severity of ICD (impulse control disorders) - Parkinson Disease | Phase 2 | Completed | University Hospital, Strasbourg, France | 117 | 2020-10-23 | 2026-03-16 |
| Screening and Multiple Intervention on Lung Epidemics Cytisine, Acetylsalicylic acid, Diet Modification and Physical Activity Increase - Inflammation, Smoking Cessation | Phase 2 | Active not recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2000 | 2019-07-23 | 2026-03-27 |
| Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer treatment with focal HIFU, PSA dosage, MRI - Prostate Cancer | Phase 2 | Completed | Hospices Civils de Lyon | 174 | 2018-09-28 | 2026-02-24 |
| Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma Anetumab Ravtansine, Blood test - Lung Neoplasms | Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2016-07-19 | 2019-05-21 |
| Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension Renal sympathicolysis, Ambulatory Blood Pressure Monitoring, Magnetic Resonance Angiography - Hypertension Resistant to Conventional Therapy, Kidney Failure, Chronic | Phase 2 | Terminated | University Hospital, Grenoble | 2 | 2016-02-01 | 2018-05-09 |
| Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients ultrasound, blood test - Endometrial Cancer | Phase 2 | Unknown | Meir Medical Center | 200 | 2015-10-01 | 2016-09-20 |
| A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer Blood Tests, CT scan, FACBC PET/MRI in a subset of participants - Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | Completed | Massachusetts General Hospital | 22 | 2015-04-01 | 2022-09-29 |
| Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) General condition, Blood pressure, Patient Reported Outcome - Rectal Cancer | Phase 2 | Unknown | Clinical Research Support Center Kyush | 74 | 2014-10-01 | 2014-11-13 |
| RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). Laboratory test, Medical history and physical examination, BW and height - Rectal Cancer | Phase 2 | Unknown | Clinical Research Support Center Kyush | 110 | 2013-09-01 | 2014-10-31 |
| Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months MenACWY-CRM197, Blood test - Meningococcal Disease | Phase 2 | Completed | Novartis Vaccines | 382 | 2008-02-01 | 2014-10-24 |
| A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To Zithromax™ (azithromycin) 500mg tablets, Endoscopic Sinus Surgery, Blood sampling for hematology - Sinusitis | Phase 2 | Completed | Pfizer | 72 | 2005-11-01 | 2011-04-21 |
| Interstitial Cystitis H&P; ECG; Blood tests; voiding diary; Cystoscopy - Interstitial Cystitis | Phase 2 | Completed | ICOS Corporation | 150 | 2003-01-01 | 2005-06-24 |
Lung Neoplasms (3) · Prostatic Neoplasms (2) · Rectal Neoplasms (2) · Adenocarcinoma of Lung (1) · Alzheimer Disease (1) · Behavior (1) · Colonic Neoplasms (1) · Cystitis, Interstitial (1) · Diabetes Mellitus, Type 2 (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Drug Resistant Epilepsy (1) · Endometrial Neoplasms (1) · Epilepsy (1) · Fatigue (1) · Heart Failure, Diastolic (1)
Clinical Research Support Center Kyush (2) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Groupe Francais De Pneumo-Cancerologie (1) · Hospices Civils de Lyon (1) · ICOS Corporation (1) · MGC Pharmaceuticals d.o.o (1) · Massachusetts General Hospital (1) · Meir Medical Center (1) · National Cancer Institute (NCI) (1) · Novartis Vaccines (1) · Pfizer (1) · Soonchunhyang University Hospital (1) · University Hospital, Grenoble (1) · University Hospital, Strasbourg, France (1) · University of Leicester (1)
United States (5) · France (4) · Israel (2) · Japan (2) · United Kingdom (2) · Canada (1) · Italy (1) · Slovenia (1) · South Korea (1)
Yasunori Emi, MD, PhD (2) · Byeo Lee Lim, Dr (1) · Gerry P McCann, MD (1) · Julien Ghelfi, Md (1) · Lyn Frumkin, M.D., Ph.D. (1) · Philip J Saylor, MD (1) · Raffit Hassan, M.D. (1) · Rubi Zomer (1) · Ugo Pastorino, MD (1) · Val Lowe, MD (1)
2016 (2), 2015 (1)